Streamlining Clinical Studies

Making research more efficient

A key advantage of using ChemoCare is the ability to mine multiple datasets directly from the system. As a result, trusts can easily access a wide range of patient records for various research purposes, making the information-gathering process much more efficient.

Whether you’re conducting clinical studies, chart reviews or anything else, our technology removes the need for laborious manual data collection so that ChemoCare users have more time to carry out their important research. It also therefore offers the potential for a larger number of studies to be done.

Users can easily access data to streamline:

research icon

Data collection for clinical studies

green person silhouette with heart monitor line below icon

Finding patients who are eligible for taking part in research

settings icon

Collection of Real World Evidence

Meanwhile, our software hosting partners, Redcentric, are one of the best in the UK, so you can rest assured that all data is kept safe and secure, for your complete peace of mind.

User-friendly system

Designed to support healthcare professionals in more efficient and effective practice, our ChemoCare technology is also equipped with an easy-to-use system which makes obtaining patient consent as straightforward as possible. So, once ChemoCare has identified those patients who are eligible to take part in trials or studies, the process for signing them up is simple.

Key benefits of ChemoCare for research:

  • Digital clinical study documentation
  • Easy identification of eligible patients
  • Support for patient consent process
  • Data dashboards to support local study and audit work

For more information about ChemoCare please call us on 028 9560 0855 or email: sales@cis-healthcare.com

What our clients say

green quotation marks left
green quotation marks right

Since we went ‘live’ in September 2020, and started the training roll-out, we are pleased with the additional functionality the upgrade has provided. Training has been delivered remotely via software platforms due to social distancing restrictions and this methodology has been efficient and successful. Feedback from end users has been positive and many clinicians prefer the new format.

Tracy Parry
Lead Cancer Services Pharmacist
Betsi Cadwaladr University Health Board

It has taken significant collaborative effort from all parties to achieve this milestone; we look forward to fully utilising the additional functionality and the upgraded software.

Dr Vikash Dodhia
Senior Site Manager and Business Management Pharmacist
East and North Hertfordshire NHS Trust

Achieving 100% live protocols represents a significant milestone for our team. We're keen to continue to maximise the Dudley Group’s use of the advanced configuration options and functionality available in ChemoCare Version 6.

Joe Whittle
Interim Principal Pharmacist
Dudley Go Live

We are pleased to announce that Airedale NHS Foundation Trust has now gone live with the planned upgrade to Chemocare V6. The clinical and IT teams at the Trust worked closely with the project team at CIS Oncology to deliver the project within the planned timeframe. The upgraded system will allow us to continue to develop our chemotherapy service and deliver on the new SACT v3 database. We are very happy with the support and project management offered by CIS which meant that the upgrade ran smoothly.

Carl Booth
Lead Pharmacist
Airedale General Hospital